Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life

doi:10.1093/cid/ciad737

. 2024 Mar 20;78(3):493-495.

doi: 10.1093/cid/ciad737.

Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life

Daniel Karlin¹, Christine Pham^{2

3}, Daisuke Furukawa⁴, Ishminder Kaur⁵, Emily Martin¹, Olivia Kates⁶, Tara Vijayan²

Affiliations

¹ Division of General Internal Medicine, Department of Medicine, University of California, Los Angeles, California, USA.
² Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, California, USA.
³ Department of Pharmaceutical Services, University of California, Los Angeles, California, USA.
⁴ Division of Infectious Diseases, Department of Medicine, Stanford University, Palo Alto, California, USA.
⁵ Division of Infectious Diseases, Department of Pediatrics, University of California, Los Angeles, California, USA.
⁶ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

PMID: 38301074
DOI: 10.1093/cid/ciad737

Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life

Daniel Karlin et al. Clin Infect Dis. 2024.

. 2024 Mar 20;78(3):493-495.

doi: 10.1093/cid/ciad737.

Authors

Daniel Karlin¹, Christine Pham^{2

3}, Daisuke Furukawa⁴, Ishminder Kaur⁵, Emily Martin¹, Olivia Kates⁶, Tara Vijayan²

Affiliations

¹ Division of General Internal Medicine, Department of Medicine, University of California, Los Angeles, California, USA.
² Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, California, USA.
³ Department of Pharmaceutical Services, University of California, Los Angeles, California, USA.
⁴ Division of Infectious Diseases, Department of Medicine, Stanford University, Palo Alto, California, USA.
⁵ Division of Infectious Diseases, Department of Pediatrics, University of California, Los Angeles, California, USA.
⁶ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

PMID: 38301074
DOI: 10.1093/cid/ciad737

No abstract available

Keywords: antibiotic stewardship; end of life care; palliative care.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. D. F. reports a grant from the National Institutes of Health (grant R25 AI 147369), unrelated to the current work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Cited by

The Use of Antibiotics at the End of Life: A Cross-Sectional Study.
Miranda-Chavez B, Fuentes-Yufra A, Hueda-Zavaleta M, Copaja-Corzo C, Flores-Cohaila JA, Rivarola-Hidalgo M. Miranda-Chavez B, et al. Health Serv Insights. 2024 Sep 15;17:11786329241280812. doi: 10.1177/11786329241280812. eCollection 2024. Health Serv Insights. 2024. PMID: 39286265 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life

Affiliations

Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources

Full Text Sources